Kinnate Biopharma Inc. Closes $35 Million Series A Financing to Establish a Chinese Joint Venture
13 mai 2021 16h02 HE | Kinnate Biopharma
Financing led by OrbiMed Asia Partners, with participation from OrbiMed Private Investments and Foresite CapitalThe joint venture will have exclusive license to develop and commercialize Kinnate’s...
Worldwide Precision Medicine Industry to 2025 - Targeted Gene Therapy Presents Opportunities
12 mars 2021 05h03 HE | Research and Markets
Dublin, March 12, 2021 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market (2020-2025) by Technology, Sequencing Technology, Products, Applications, End-Users, Route of Administration,...
Outlook on the CAR-T Cell Therapy Global Market to 2027 - Capitalize on Emerging Trends
05 janv. 2021 06h33 HE | Research and Markets
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials and Trends, 2021" report has been added to's offering. ...
Kinnate Biopharma Announces Pricing of Initial Public Offering
02 déc. 2020 22h02 HE | Kinnate Biopharma
SAN FRANCISCO and SAN DIEGO, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small...
Global Theranostics Markets Report 2020: Oncology Segment Market for Theranostics Should Grow from $73.1 Billion in 2020 to $119.7 Billion by 2025
26 oct. 2020 07h23 HE | Research and Markets
Dublin, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The "Theranostics: Global Markets" report has been added to's offering. The global market for theranostics should grow from $80.4...
AMR Logo.png
Uveitis Treatment Market to Reach $687.4 Mn, by 2026: AMR
22 juin 2020 10h26 HE | Allied Market Research
Portland, OR, June 22, 2020 (GLOBE NEWSWIRE) -- According to the report, the global uveitis treatment market was pegged at $500.7 million in 2019 and is expected to reach $687.4 million by 2026,...
Global Cancer Stem Cell Market to Reach Nearly $2B by 2022
17 janv. 2018 12h29 HE | BCC Research
WELLESLEY, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Cancer stem cells have been found in a range of human tumors and are potential targets for cancer treatment. The global cancer stem cell...
New Research Study Demonstrates Applicability of VisionGate’s 3-Dimensional Cell-CT™ Imaging and Analysis Platform
11 déc. 2017 15h27 HE | VisionGate, Inc.
Seattle, WA, Dec. 11, 2017 (GLOBE NEWSWIRE) -- New research conducted by Arizona State University’s (ASU) Biodesign Institute and published in Science Advances (published by the American Association...
Admera Health Expands Oncology Test Portfolio with Launch of OncoGxSelect™ at the AMP 2016 Annual Meeting
09 nov. 2016 09h13 HE | Admera Health, LLC
SOUTH PLAINFIELD, N.J. and CHARLOTTE, N.C., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Molecular diagnostics company, Admera Health announced the official launch of OncoGxSelect™ while exhibiting at the...
MolecularMD Corp. Obtains Exclusive License to LKB1 Uses in Non-Small Cell Lung Cancer
28 janv. 2013 08h30 HE | MolecularMD
PORTLAND, OR--(Marketwire - Jan 28, 2013) - MolecularMD Corp. announced today that it has entered into a license agreement granting the company exclusive patent rights to cancer diagnosis...